Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail

G Roopashri, K Jayanthi, R Guruprasad, G Roopashri, K Jayanthi, R Guruprasad

Abstract

Background and objectives: Oral mucositis is a common and debilitating complication of radiotherapy, which is associated with significant morbidity. It is therefore extremely important that mucositis be prevented, or at least treated to reduce its severity and sequelae. The objective of the study was to manage oral mucositis induced by radiotherapy and to reduce pain by using Benzydamine hydrochloride (0.15%), Chlorhexidine (0.2%), and Povidone iodine (5%).

Results: Benzydamine hydrochloride was observed to be effective and delayed the development of severe form of mucositis and appears more efficient in the management of radiation-induced mucositis.

Conclusion: Benzydamine hydrochloride (0.15%) is safe, well tolerated, helps not just in delaying the progression of mucositis but also reduces the intensity of pain.

Keywords: Benzydamine hydrochloride; chlorhexidine; oral mucositis; povidone iodine.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy /radiotherapy.Options for prevention and treatment. CA Cancer J Clin. 2001;51:290–315.
    1. Paccitti Symptomatic treatment of radiation-induced mucositis in head and Neck cancer: Current practice, literature review and evidence-based Recommendations. J Radiother Pract. 2004;4:47–54.
    1. Sciubba J, Goldenberg D. Oral Complications of Radiotherapy. Lancet Oncol. 2000;7:175–83.
    1. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Med. 2003;14:199–202.
    1. trotti Andy. Toxicity in head and neck cancer. A Review of Trends and Issues. Int J Radiation Oncology Biol Phys. 2000;47:1–12.
    1. Plevová P. Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis review. Oral Oncol. 1999;35:453–70.
    1. Scully C, Sonis S, Diz PD. Oral Mucositis. Oral Dis. 2006;12:229–41.
    1. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy.A systematic literature review. Radiother Oncol. 2003;66:253–62.
    1. Beumer J, Curtis T, Harrison RE. Radiation therapy of the oral cavity.Sequelae and management. Head Neck Surg. 1979;1:301–12.
    1. Martin S. Greenberg. In: Glick M, editor. Burket's Oral Medicine. 9th ed. BC. Decker Inc;
    1. Martin MV. Irradiation mucositis: A reappraisal. Oral Oncol. 1993;29:1–2.
    1. Foote RL, Loprinzi CL, Frank AR, O’Fallon JR, Gulavita S, Tewfik HH, et al. Randomized trial of a Chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol. 1994;12:2630–3.
    1. Epstein JB, Silverman S, Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCl for Prophylaxis of Radiation-Induced Oral Mucositis.Results from a Multicentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cancer. 2001;92:1–15.
    1. Henson DF, Arnold R. Oral Mucositis: Diagnosis and Assessment, Fast Facts and Concepts #121 and WHO criteria. Available from: .
    1. Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, et al. The effects of Chlorhexidine and Benzydamine mouth washes on mucositis induced by therapeutic radiation. Clin radiol. 1988;39:291–4.
    1. Mody RN, Talukdar S. Efficacy of Benzydamine hydrochloride oral rinses in Radiation mucositis. J Indian Dent Assoc. 1993;64:93–7.
    1. Kim JH, Chu FC, Lakshmi V, Houde R. Benzydamine HCl.A new agent for the treatment of radiation mucositis of the oropharaynx. Am J Clin Oncol. 1986;9:132–4.

Source: PubMed

3
Subscribe